NCT00150319View on ClinicalTrials.gov

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Kidney Failure
Interventions
DRUG

Vfend®; I.V.

Trial Locations (6)

37920

Pfizer Investigational Site, Knoxville

55404

Pfizer Investigational Site, Minneapolis

70118

Pfizer Investigational Site, New Orleans

70119

Pfizer Investigational Site, New Orleans

78727

Pfizer Investigational Site, Austin

78758

Pfizer Investigational Site, Austin

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY